Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. (10th July 2014)
- Record Type:
- Journal Article
- Title:
- Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. (10th July 2014)
- Main Title:
- Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England
- Authors:
- Winstone, Anne Marie
Stellitano, Lesley
Verity, Christopher
Andrews, Nick
Miller, Elizabeth
Stowe, Julia
Shneerson, John - Abstract:
- <abstract abstract-type="main" id="dmcn12522-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="dmcn12522-sec-0001" sec-type="section"> <title>Aim</title> <p>The aim of this study was to investigate whether children in England with narcolepsy who received the ASO3 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix) differed clinically from unvaccinated patients.</p> </sec> <sec id="dmcn12522-sec-0002" sec-type="section"> <title>Method</title> <p>A retrospective review was conducted in children with narcolepsy diagnosed by sleep centres and paediatric neurologists in 16 English hospitals. The inclusion criteria were patient age 4 to 18 years, onset of narcolepsy after January 2008, and diagnosis by the time of the key data‐gathering visit in 2011. Clinical data came from hospital notes and general practitioner questionnaires. An expert panel validated the diagnoses.</p> </sec> <sec id="dmcn12522-sec-0003" sec-type="section"> <title>Results</title> <p>Seventy‐five patients with narcolepsy were identified (43 males, 32 females; mean age at onset 10y 4mo, range 3–18y). Of these patients, 11 received the Pandemrix vaccine before narcolepsy onset. On first presentation, there were more frequent reports of cataplexy, among other features, in vaccinated than in unvaccinated patients (82% vs 55%), but only excessive weight gain (55% vs 20%) was significantly more frequent (<italic>p</italic>=0.03). Facial hypotonia (<italic>p</italic>=0.03) and tongue<abstract abstract-type="main" id="dmcn12522-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="dmcn12522-sec-0001" sec-type="section"> <title>Aim</title> <p>The aim of this study was to investigate whether children in England with narcolepsy who received the ASO3 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix) differed clinically from unvaccinated patients.</p> </sec> <sec id="dmcn12522-sec-0002" sec-type="section"> <title>Method</title> <p>A retrospective review was conducted in children with narcolepsy diagnosed by sleep centres and paediatric neurologists in 16 English hospitals. The inclusion criteria were patient age 4 to 18 years, onset of narcolepsy after January 2008, and diagnosis by the time of the key data‐gathering visit in 2011. Clinical data came from hospital notes and general practitioner questionnaires. An expert panel validated the diagnoses.</p> </sec> <sec id="dmcn12522-sec-0003" sec-type="section"> <title>Results</title> <p>Seventy‐five patients with narcolepsy were identified (43 males, 32 females; mean age at onset 10y 4mo, range 3–18y). Of these patients, 11 received the Pandemrix vaccine before narcolepsy onset. On first presentation, there were more frequent reports of cataplexy, among other features, in vaccinated than in unvaccinated patients (82% vs 55%), but only excessive weight gain (55% vs 20%) was significantly more frequent (<italic>p</italic>=0.03). Facial hypotonia (<italic>p</italic>=0.03) and tongue protrusion (<italic>p</italic>=0.01) were eventually seen more frequently in vaccinated children. When considering patients diagnosed within a year of onset, vaccinated children were not diagnosed more rapidly than unvaccinated children.</p> </sec> <sec id="dmcn12522-sec-0004" sec-type="section"> <title>Interpretation</title> <p>Some symptoms and signs of narcolepsy were more frequently reported in Pandemrix–vaccinated patients. There was no evidence of the more rapid diagnosis in vaccinated patients that has been reported in Finland and Sweden.</p> </sec> </abstract> … (more)
- Is Part Of:
- Developmental medicine & child neurology. Volume 56:Number 11(2014:Nov.)
- Journal:
- Developmental medicine & child neurology
- Issue:
- Volume 56:Number 11(2014:Nov.)
- Issue Display:
- Volume 56, Issue 11 (2014)
- Year:
- 2014
- Volume:
- 56
- Issue:
- 11
- Issue Sort Value:
- 2014-0056-0011-0000
- Page Start:
- 1117
- Page End:
- 1123
- Publication Date:
- 2014-07-10
- Subjects:
- Child development -- Periodicals
Pediatric neurology -- Periodicals
616.8 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1469-8749 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/dmcn.12522 ↗
- Languages:
- English
- ISSNs:
- 0012-1622
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.055000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3524.xml